Complete clinical and virological remission of refractory HIV-related Kaposi's sarcoma with pegylated interferon alpha.
van der Ende
Marchina
M
Mulder
Jan Willem
JW
van den Berge
Marcel
M
Blok
Willem
W
Schutten
Martin
M
D000328:Adult; D023241:Antiretroviral Therapy, Highly Active; D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D011092:Polyethylene Glycols; D011994:Recombinant Proteins; D012514:Sarcoma, Kaposi / Q000188:drug therapy*; D016896:Treatment Outcome
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C417083:peginterferon alfa-2b